1. Cancer Hallmarks and MicroRNAs: The Therapeutic Connection
    Katrien Van Roosbroeck et al, 2017, miRNA and Cancer CrossRef
  2. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
    Ningni Jiang et al, 2020, Molecular Biology Reports CrossRef
  3. miR-195 suppresses abdominal aortic aneurysm through the TNF-α/NF-κB and VEGF/PI3K/Akt pathway
    Xiaohui Ma et al, 2018, International Journal of Molecular Medicine CrossRef
  4. RNA interactions in right ventricular dysfunction induced type II cardiorenal syndrome
    Kaitong Chen et al, 2021, Aging CrossRef
  5. miRNA‑195 suppresses cell proliferation of ovarian cancer cell by regulating VEGFR2 and AKT signaling pathways
    Jun Chen, 2018, Molecular Medicine Reports CrossRef
  6. PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3/microRNA-195-5p/SGK1
    Shu-cheng Liu et al, 2022, Clinical Epigenetics CrossRef
  7. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway
    Ge Wang et al, 2023, Phytomedicine CrossRef
  8. Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells
    Jinqiu Li et al, 2020, Free Radical Research CrossRef
  9. Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
    Antonella Argentiero et al, 2020, Journal of Clinical Medicine CrossRef
  10. MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma
    Haifeng Pang et al, 2018, Molecular Medicine Reports CrossRef
  11. miR‐452 promotes cell metastasis and the epithelial to mesenchymal by targeting SOX7 in clear‐cell renal‐cell carcinoma
    Feng Liu et al, 2019, Journal of Cellular Biochemistry CrossRef
  12. MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
    Sandra Gallach et al, 2017, Oncotarget CrossRef
  13. Epigenetics in renal cell cancer: mechanisms and clinical applications
    Sophie C. Joosten et al, 2018, Nature Reviews Urology CrossRef
  14. miRNA in Molecular Diagnostics
    Maja Matulić et al, 2022, Bioengineering CrossRef
  15. Prostate cancer health disparities: An immuno-biological perspective
    Sanjay Kumar et al, 2018, Cancer Letters CrossRef
  16. Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway
    Xiao-Zhong Liao et al, 2017, Cancer Cell International CrossRef
  17. Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis
    Fanchang Zeng et al, 2022, Journal of Receptors and Signal Transduction CrossRef
  18. Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
    Hamidreza Maroof et al, 2019, Current Cancer Drug Targets CrossRef
  19. Non-coding RNA and reprogrammed mitochondrial metabolism in genitourinary cancer
    Sandiya Thirunavukkarasu et al, 2024, Frontiers in Genetics CrossRef
  20. LINC01535 Attenuates ccRCC Progression through Regulation of the miR-146b-5p/TRIM2 Axis and Inactivation of the PI3K/Akt Pathway
    Zhiming Zhang et al, 2022, Journal of Oncology CrossRef
  21. Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
    Guiyun Cheng et al, 2020, Frontiers in Oncology CrossRef
  22. Genetic and Epigenetic Modifications in Pancreatic Cancer
    Sanjay Kumar et al, 2018, Epigenetic Mechanisms in Cancer CrossRef
  23. Research progress in the prevention and treatment of liver fibrosis in Chinese medicine based on miRNAs molecular regulation of angiogenesis
    Jiahui Wang et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
  24. Mechanisms of lncRNA/microRNA interactions in angiogenesis
    Zhuo Zhao et al, 2020, Life Sciences CrossRef

  25. Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression


    Keng Lin et al, 2020, Cancer Management and Research CrossRef